XT
ANRO icon

XTX Topco’s Alto Neuroscience ANRO Stock Holding History

XTX Topco’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
46,601
+6,760
+17% +$156K 0.02% 1597
2026
Q1 		$896K Buy
39,841
+19,017
+91% +$352K 0.02% 1507
2025
Q4 		$371K Buy
20,824
+5,078
+32% +$63.9K 0.01% 1879
2025
Q3 		$63.3K Buy
+15,746
New +$52.2K ﹤0.01% 2123

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

XTX Topco's ANRO Position: Q2 2026 in Review

XTX Topco increased its Alto Neuroscience (ANRO) stake by 17% in Q2 2026, buying an estimated $156K and bringing the position to 46,601 shares worth $1.23M. The position accounts for 0.02% of the portfolio, ranked #1597.

XTX Topco first reported a position in ANRO in Q3 2025 and has held it in 4 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • XTX Topco held 46,601 shares of Alto Neuroscience worth $1.23M as of Q2 2026.
  • XTX Topco bought 6,760 Alto Neuroscience shares in Q2 2026, an estimated $156K.
  • Alto Neuroscience made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1597 holding.
  • XTX Topco first reported a position in Alto Neuroscience in Q3 2025 and has held it in 4 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.